Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas.
Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas.
复制标题
DOI:
10.3390/diagnostics11040681
复制
发表时间:
2021-04-09
期刊:
影响因子:
--
通讯作者:
Fujii Y
中科院分区:
文献类型:
--
作者:
On J;Natsumeda M;Watanabe J;Saito S;Kanemaru Y;Abe H;Tsukamoto Y;Okada M;Oishi M;Yoshimura J;Kakita A;Fujii Y
Recent studies have suggested the feasibility of detecting H3K27M mutations in the cerebrospinal fluid of diffuse midline glioma (DMG) patients. However, cerebrospinal fluid from patients in these studies were collected mainly during biopsy, ventriculo-peritoneal shunt procedures or postmortem. We assessed circulating tumor DNA (ctDNA) extracted from cerebrospinal fluid (CSF) and plasma in a series of 12 radiographically suspected and/or pathologically confirmed diffuse midline glioma patients and assessed for H3F3A K27M mutation using digital droplet PCR. In 10 patients, CSF was obtained by lumbar puncture at presentation. A definitive detection of H3F3A K27M mutation was achieved in only one case (10%); H3F3A K27M mutation was suspected in three other cases (30%). H3F3A K27M mutation was detected in two patients in CSF obtained by ventricular tap during a ventriculo-peritoneal shunt for obstructive hydrocephalus. Cases in which a definitive assessment was possible (definite H3F3A K27M or definite H3F3A wildtype) tended to be younger (median 7.5 years vs. 40.5 years; p = 0.07) and have a higher concentration of CSF protein (median 123 mg/dL vs. 27.5 mg/dL; p = 0.21) compared to nondefinite cases. Low proliferation and apoptotic rates seemed to be characteristics of DMG unfavorable for liquid biopsy. More advanced lesions with necrosis and evidence of dissemination were unlikely to be candidates for lumbar puncture due to the fear of exacerbating obstructive hydrocephalus. Methods to safely sample CSF and a more sensitive detection of ctDNA are necessary for reliable liquid biopsy of DMG at presentation.
登录
查看更多内容
DOI:
10.1158/1078-0432.ccr-18-1345
发表时间:
2018-12-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Panditharatna E;Kilburn LB;Aboian MS;Kambhampati M;Gordish-Dressman H;Magge SN;Gupta N;Myseros JS;Hwang EI;Kline C;Crawford JR;Warren KE;Cha S;Liang WS;Berens ME;Packer RJ;Resnick AC;Prados M;Mueller S;Nazarian J
通讯作者:
Nazarian J
影响因子:
30.8
作者:
Wu G;Diaz AK;Paugh BS;Rankin SL;Ju B;Li Y;Zhu X;Qu C;Chen X;Zhang J;Easton J;Edmonson M;Ma X;Lu C;Nagahawatte P;Hedlund E;Rusch M;Pounds S;Lin T;Onar-Thomas A;Huether R;Kriwacki R;Parker M;Gupta P;Becksfort J;Wei L;Mulder HL;Boggs K;Vadodaria B;Yergeau D;Russell JC;Ochoa K;Fulton RS;Fulton LL;Jones C;Boop FA;Broniscer A;Wetmore C;Gajjar A;Ding L;Mardis ER;Wilson RK;Taylor MR;Downing JR;Ellison DW;Zhang J;Baker SJ
通讯作者:
Baker SJ
影响因子:
12.7
作者:
Castel D;Philippe C;Calmon R;Le Dret L;Truffaux N;Boddaert N;Pagès M;Taylor KR;Saulnier P;Lacroix L;Mackay A;Jones C;Sainte-Rose C;Blauwblomme T;Andreiuolo F;Puget S;Grill J;Varlet P;Debily MA
通讯作者:
Debily MA
DOI:
10.1097/nen.0000000000000216
发表时间:
2015-08
影响因子:
3.2
作者:
Taylor IC;Hütt-Cabezas M;Brandt WD;Kambhampati M;Nazarian J;Chang HT;Warren KE;Eberhart CG;Raabe EH
通讯作者:
Raabe EH
影响因子:
1.9
作者:
Abe H;Natsumeda M;Kanemaru Y;Watanabe J;Tsukamoto Y;Okada M;Yoshimura J;Oishi M;Fujii Y
通讯作者:
Fujii Y